Prediction of quality markers of traditional Chinese medicines based on network pharmacology

Abstract Network pharmacology is a powerful tool to reflect the pharmacologically active effects, mechanism of action and toxic activity of traditional Chinese medicines (TCMs). The ingredients of TCMs, associated with quality control of TCM products, are those fundamental chemicals that exhibit biological activities. A great amount of effort has been made by scientists in that field in order to improve the quality of TCMs, though the approaches to determine their quality and the TCM theory and compatibility rules remain ambiguous. Now some methods and technologies must be applied to predict and explore the quality marker (Q-marker) for quality control, as well as to clarify the factors affecting the quality of TCM, which may give new insight into rational ground of establishment of appropriate quality control and assessment system. In this review paper, authors focus on the prediction of quality markers of TCMs by network pharmacology based on three aspects: (1) from network medicine to network pharmacology, (2) complex network system of traditional Chinese medicine, and (3) predicting TCM quality markers based on network pharmacology. Authors proposed the research pattern on network pharmacology based on biological and medical networks, and further TCM network pharmacology based on substantial basis of TCM formulae, and the idea of “effect-ingredient-target-fingerprint” to predict and recognize the TCM Q-marker was the ultimate goal. In addition, authors yet noted how to make full use of the advantages of network toxicology to provide new ideas for the toxicity study of complex TCM systems and the prediction of TCM toxicity markers.

[1]  Shao Li,et al.  [Framework and practice of network-based studies for Chinese herbal formula]. , 2007, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[2]  Wen Gao,et al.  Discovery of discriminatory quality control markers for Chinese herbal medicines and related processed products by combination of chromatographic analysis and chemometrics methods: Radix Scutellariae as a case study , 2017, Journal of pharmaceutical and biomedical analysis.

[3]  D. Guo,et al.  Quality marker of TCMs: concept and applications. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  Yibin Feng,et al.  A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines , 2017, Molecules.

[5]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[6]  Ke Li,et al.  Identification of quality markers of Yuanhu Zhitong tablets based on integrative pharmacology and data mining. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  Liang Liu,et al.  Quality transitivity and traceability system of herbal medicine products based on quality markers. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[9]  Xuegong Zhang,et al.  Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.

[10]  Ning Wang,et al.  A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets , 2017, International journal of molecular sciences.

[11]  Gang Bai,et al.  The method of quality marker research and quality evaluation of traditional Chinese medicine based on drug properties and effect characteristics. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  Y. Chai,et al.  A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement. , 2016, Molecular bioSystems.

[13]  Shao Li,et al.  Network Pharmacology in Traditional Chinese Medicine , 2014, Evidence-based complementary and alternative medicine : eCAM.

[14]  Yan-qi Han,et al.  The comparative pharmacokinetic study of Yuanhu Zhitong prescription based on five quality-markers. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  Thomas J. Anastasio,et al.  Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease , 2015, Front. Pharmacol..

[16]  Huali Zuo,et al.  A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction , 2018, Scientific Reports.

[17]  Yong Wang,et al.  BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine , 2016, Scientific Reports.

[18]  Xiong-Zhi Wu,et al.  Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients , 2017, Oncotarget.

[19]  Wen-bin Hou,et al.  A New Concept on Quality Marker for Quality Assessment and Process Control of Chinese Medicines , 2017 .

[20]  A. Chiang,et al.  Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.

[21]  Ling Wang,et al.  Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment. , 2017, Journal of ethnopharmacology.

[22]  Yibin Feng,et al.  A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae , 2017, Molecules.

[23]  Changxiao Liu,et al.  Approaches to establish Q-markers for the quality standards of traditional Chinese medicines , 2017, Acta pharmaceutica Sinica. B.

[24]  Jintao Xue,et al.  Network pharmacology‐based prediction of the active ingredients, potential targets, and signaling pathways in compound Lian‐Ge granules for treatment of diabetes , 2018, Journal of cellular biochemistry.

[25]  A. Marshall,et al.  High resolution mass spectrometry. , 2012, Analytical chemistry.

[26]  J. Loscalzo,et al.  The Emerging Paradigm of Network Medicine in the Study of Human Disease , 2012, Circulation research.

[27]  Calvin Yu-Chian Chen,et al.  Network pharmacology-based approach of novel traditional Chinese medicine formula for treatment of acute skin inflammation in silico , 2017, Comput. Biol. Chem..

[28]  J. Hoheisel,et al.  Toxicogenomics for the Prediction of Toxicity Related to Herbs from Traditional Chinese Medicine , 2010, Planta medica.

[29]  Rui Liu,et al.  Network Pharmacology Bridges Traditional Application and Modern Development of Traditional Chinese Medicine , 2015 .

[30]  Ruo-lin Zhao,et al.  Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice. , 2018, Journal of ethnopharmacology.

[31]  Peter Jüni,et al.  Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis , 2012, Annals of the rheumatic diseases.

[32]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[33]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[34]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[35]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[36]  Haixia Chen,et al.  Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review , 2017, Front. Pharmacol..

[37]  Xue-feng Xiao,et al.  Development and Application of Network Toxicology in Safety Research of Chinese Materia Medica , 2015 .

[38]  Changxiao Liu,et al.  A strategy for the discovery and validation of toxicity quality marker of Chinese medicine based on network toxicology. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[39]  Shao Li,et al.  Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula , 2009 .

[40]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[41]  Shao Li,et al.  [Network target: a starting point for traditional Chinese medicine network pharmacology]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[42]  Xiaohui Fan,et al.  [Network toxicology and its application to traditional Chinese medicine]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[43]  Changxiao Liu,et al.  An integrated approach to uncover quality marker underlying the effects of Alisma orientale on lipid metabolism, using chemical analysis and network pharmacology. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[44]  Jiansong Fang,et al.  Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease. , 2018, Chinese journal of natural medicines.

[45]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[46]  Gang Bai,et al.  From quality markers to data mining and intelligence assessment: A smart quality-evaluation strategy for traditional Chinese medicine based on quality markers. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.